ClinConnect ClinConnect Logo
Search / Trial NCT07021105

COMPARISON OF PLAIN BLOCKS FOR POSTOPERATIVE PAIN MANAGEMENT IN GYNECOLOGICAL ABDOMINAL SURGERIES

Launched by CUKUROVA UNIVERSITY · Jun 12, 2025

Trial Information

Current as of November 14, 2025

Enrolling by invitation

Keywords

Gynecologic Surgery Transversus Abdominis Plane Block Erector Spinae Plaen Block Quadratus Lumborum Block Morphine Consumption

ClinConnect Summary

This study is comparing three different nerve-block techniques (ESP, QLB, and TAP) with no block to see which helps reduce pain after gynecologic abdominal surgery. In four groups of about 20 people each, participants will receive one of the blocks or no block before waking up, with injections given under ultrasound guidance. The main goal is to see how much morphine patients use in the first 24 hours after surgery. Researchers will also look at pain scores, overall satisfaction, need for extra pain medicine, and any side effects.

Who can participate? Women aged 18–69 who are scheduled for major gynecologic abdominal surgery and are generally in good health (ASA 1–2). People with very high surgical risk, obesity (BMI over 40), bleeding disorders or anticoagulant use, allergies to study drugs, or inability to use a patient-controlled analgesia device are not eligible. The study is currently enrolling in Adana, Turkey, and plans to include about 80 participants in total. Results are expected later in 2025.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • aged between 18 and 69 years, with ASA 1-2 score scheduled to undergo major gynecological abdominal surgery
  • Exclusion Criteria:
  • ASA score 3 or above, patients younger than 18 or older than 69 years, patients with bleeding disorders or using anticoagulants, patients with a body mass index over 40, patients with known allergies to any drugs used in the study, and patients who could not or did not wish to use Patient-Controlled Analgesia (PCA) device

About Cukurova University

Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.

Locations

Adana, Turkey

Adana, Sarıçam, Turkey

Patients applied

0 patients applied

Trial Officials

Hakkı Ünlügenç, Professör

Study Director

Cukurova University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported